197. Hulbert AJ, Rana T, Couture P. The acyl composition of mammalianphospholipids: an allometric analysis. Comp Biochem Physiol B BiochemMol Biol 2002;132:515-27.198. Dwyer JH, Allayee H, Dwyer KM, Fan J, Wu H, Mar R, LusisAJ, Mehrabian M. Arachidonate 5-lipoxygenase promoter genotype,dietary arachidonic acid, and atherosclerosis. N Engl J Med2004;350:29-37.199. Lauritzen L, Jorgensen MH, Hansen HS, Michaelsen KF. Fluctuationsin human milk long-chain PUFA levels in relation to dietary fishintake. Lipids 2002;37:237-44.200. Al MD, van Houwelingen AC, Hornstra G. Long-chain polyunssaturatedfatty acids, pregnancy, and pregnancy outcome. Am J Clin Nutr2000;71:285S-91S.201. Montgomery C, Speake BK, Cameron A, Sattar N, Weaver LT. Maternaldocosahexaenoic acid supplementation and fetal accretion. Br JNutr 2003;90:135-45.202. van den Ham EC, van Houwelingen AC, Hornstra G. Evaluation ofthe relation between n-3 and n-6 fatty acid status and parity in nonpregnantwomen from the Netherlands. Am J Clin Nutr 2001;73:622-7.203. Hansen AE, Wiese HF, Boelsche AN, Haggard ME, Adam DJD,Davis H. Role of Linoleic acid in infant nutrition. Clinical and chemicalstudy of 428 infants fed on milk mixtures varying in kind adnamount of fat. Pediatrics 1963;171-92.204. Hansen HS. Linoleic acid and epidermal water barrier. In: In GalliC and Simopoulos AP (Eds): editor. Dietary w3 and w6 Fatty Acids:Biol<strong>og</strong>ical Effects and Nutritional Essentiality.London: Plenum Press;1989.205. Phinney SD, Clarke SD, Odin RS, Moldawer LL, Blackburn Gl, BistrianBR. Therm<strong>og</strong>enesis secondary to transdermal water loss causesgrowth retardation in essential fatty acid-deficient rats. Metabolism1993;42:1022-6.121
<strong>Kost</strong> <strong>til</strong> <strong>gravide</strong>206. Cunnane SC. Problems with essential fatty acids: time for a new paradigm?Pr<strong>og</strong> Lipid Res 2003;42:544-68.207. Bourre JM, Bonneil M, Chaudiere J, Clement M, Dumont O, DurandG, Lafont H, Nalbone G, Pascal G, Piciotti M. Structural andfunctional importance of dietary polyunsaturated fatty acids in thenervous system. Adv Exp Med Biol 1992;318:211-29.208. Farquharson J, Cockburn F, Patrick WA, Jamieson EC, L<strong>og</strong>an RW.Infant cerebral cortex phospholipid fatty-acid composition and diet.Lancet 1992;340:810-3.209. Olsen SF, Secher NJ, Tabor A, Weber T, Walker JJ, Gluud C.Randomised clinical trials of fish oil supplementation in high riskpregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team. BJOG2000;107:382-95.210. Olsen SF, Sorensen JD, Secher NJ, Hedegaard M, Henriksen TB,Hansen HS, Grant A. Randomised controlled trial of effect of fish-oilsupplementation on pregnancy duration. Lancet 1992;339:1003-7.211. Smuts CM, Huang M, Mundy D, Plasse T, Major S, Carlson SE. Arandomized trial of docosahexaeonic acid supplementation duringthe third trimester of pregnancy. Obstet Gynecol 2003;101:469-79.212. Onwude JL, Lilford RJ, Hjartardottir H, Staines A, Tuffnell D. Arandomised double blind placebo controlled trial of fish oil in highrisk pregnancy. Br J Obstet Gynaecol 1995;102:95-100.213. Helland IB, Saugstad OD, Smith L, Saarem K, Solvoll K, Ganes T,Drevon CA. Similar effects on infants of n-3 and n-6 fatty acids supplementationto pregnant and lactating women. Pediatrics 2001;108:NIL23-NIL32.214. Bulstra-Ramakers MT, Huisjes HJ, Visser GH. The effect of 3geicosapentaenoic acid daily on recurrence of intrauterine growth retardationand pregnancy induced hypertension. Br J Obstet Gynaecol1995;102:123-6.122
- Page 1 and 2:
Kost til gravideDet videnskabelige
- Page 3 and 4:
Kost til gravideGrafisk produktion:
- Page 5 and 6:
Kost til gravide2. Områder vedrør
- Page 7 and 8:
Kost til gravideResuméErnæringsr
- Page 9 and 10:
Kost til gravideKommissoriumErnæri
- Page 11 and 12:
Kost til gravideTabel 1. fortsatEks
- Page 13 and 14:
Kost til gravideAnbefalinger for in
- Page 15 and 16:
Kost til gravidemineraler (fx jod,
- Page 17 and 18:
Kost til gravideSundhedsstyrelsen (
- Page 19 and 20:
Kost til gravideEn negativ virkning
- Page 21 and 22:
Kost til graviderelative risiko er
- Page 23 and 24:
Kost til gravidetiv undersøgelse a
- Page 25:
Kost til gravide1.3 Specifikke råd
- Page 30 and 31:
at finde frem til den mindste jernd
- Page 32 and 33:
etyder det, at 210 gravide er homoz
- Page 34 and 35:
ligt at få tilstrækkeligt folat g
- Page 36 and 37:
type misdannelser. Undersøgelsens
- Page 38 and 39:
tager folsyre som anbefalet, og rap
- Page 40 and 41:
serne, som ofte samles under betegn
- Page 42 and 43:
anderledes under en graviditet end
- Page 44 and 45:
helleflynder, oliefisk (oscolar), s
- Page 46 and 47:
Methylkviksølv har en eliminations
- Page 48 and 49:
Har tingene ændret sig, siden råd
- Page 50 and 51:
ødspætte og torsk fra Atlanterhav
- Page 52 and 53:
etinol til retinolsyre (nødvendigt
- Page 55 and 56:
Kost til gravideFøtalt alkoholsynd
- Page 57 and 58:
Kost til gravidefekter relateret ti
- Page 59 and 60:
Kost til gravide1.3.7 Mulige skadel
- Page 61 and 62:
Kost til gravidemellem koffeinindta
- Page 63 and 64:
62Kost til gravide
- Page 65 and 66:
Kost til gravideDet femte afsnit vi
- Page 67 and 68:
Kost til gravideindhold af arachido
- Page 69 and 70:
Kost til gravideGraviditetslængdeF
- Page 71 and 72: Kost til gravideaf graviditeten. B
- Page 73 and 74: Kost til gravidekomme i enkelte for
- Page 75 and 76: Kost til gravideKonklusion.Den grav
- Page 77 and 78: Kost til gravideForeløbig er konkl
- Page 79 and 80: Kost til gravideDer er påvist en s
- Page 81 and 82: Kost til gravidenedsætte risikoen
- Page 83 and 84: Kost til gravideblev også undersø
- Page 85 and 86: 84Kost til gravide
- Page 87 and 88: Kost til gravideDer er ikke beskrev
- Page 89 and 90: Kost til gravideCalcium og knoglest
- Page 91 and 92: Kost til gravidesvangerskabsforgift
- Page 93 and 94: Kost til gravideikke kendes med sik
- Page 96 and 97: 4:OrdforklaringerAnæmiApgar scoreA
- Page 98 and 99: HypertensionHæmatomHæmjernHæmogl
- Page 100 and 101: Særlig form for interventionsunder
- Page 102 and 103: 5:Referencer1. Barn i vente. Gravid
- Page 104 and 105: 21. Kirke PN, Daly LE, Elwood JH, f
- Page 106 and 107: 39. Weiss JL, Malone FD, Emig D, Ba
- Page 108 and 109: 61. Nokes C, van den Bosch C, Bundy
- Page 110 and 111: 80. O’Brien KO, Zavaleta N, Caulf
- Page 112 and 113: 101. Wald NJ, Law MR, Morris JK, Wa
- Page 114 and 115: 122. Andersen JK, Büchert A, Koch
- Page 116 and 117: 139. Hurst CH, DeVito MJ, Setzer RW
- Page 118 and 119: 157. Albertsen K, Andersen AM, Olse
- Page 120 and 121: 176. Gianelli M, Doyle P, Roman E,
- Page 124 and 125: 215. Moriguchi T, Salen N Jr. Recov
- Page 126 and 127: 233. De Vriese SR, Christophe AB, M
- Page 128 and 129: 253. Cockburn F, Belton NRE, Purvis
- Page 130 and 131: 271. Toppari J, Larsen JC, Christia
- Page 132 and 133: 291. Shiell AW, Campbell-Brown M, H
- Page 134 and 135: 6:Appendiks 1:Danske og udenlandske
- Page 136 and 137: FOLSYRE/FOLATCALCIUMJERNSST (a)Tils
- Page 138 and 139: ESSENTIELLE FEDTSYRERVÆGTSTIGNING/
- Page 140 and 141: 139
- Page 142: ErnæringsrådetSydmarken 32D2860 S